
Curis, Inc.
CRISHealthcare|Biotechnology|US
$0.91
+0.06 (+6.65%)
Cash / Share
$2.63
Ownership Breakdown
82.8%
Float
1.9M
Shares Outstanding
1.6M
Float Shares
Major Holders (23)
Combined: 142.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | IA, HC | 9.99% | 4,215,165 | Apr 24, 2026 | 13D/G |
| Daniel Mack | Individual | 9.99% | 4,215,165 | Apr 24, 2026 | 13D/G |
| Wilmot B. Harkey | Individual | 9.99% | 4,215,165 | Apr 24, 2026 | 13D/G |
| Thomas A. Satterfield, Jr. | Individual | 9.90% | 3,957,950 | May 14, 2026 | 13D/G |
| Stonepine Capital Management, LLC | IA, OO | 9.90% | 4,025,992 | Mar 27, 2026 | 13D/G |
| Jon M. Plexico | HC, IN | 9.90% | 4,025,992 | Mar 27, 2026 | 13D/G |
| Stonepine GP, LLC | Other | 9.90% | 4,025,992 | Mar 27, 2026 | 13D/G |
| Stonepine Capital, L.P. | Partnership | 9.90% | 4,025,992 | Mar 27, 2026 | 13D/G |
| Bleichroeder Holdings LLC | Holding company | 9.90% | 1,035,662 | Mar 31, 2025 | 13D/G |
| Andrew Gundlach | Holding company | 9.90% | 1,035,662 | Mar 31, 2025 | 13D/G |
| Bleichroeder LP | Investment adviser | 9.90% | 1,035,662 | Mar 31, 2025 | 13D/G |
| Nantahala Capital Partners Limited Partnership | Partnership | 6.98% | 2,944,000 | Apr 7, 2026 | 13D/G |
| Steven Boyd | HC, IN | 4.99% | 679,033 | May 15, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 679,033 | May 15, 2026 | 13D/G |
| Marc Elia | HC, IN | 4.80% | 620,167 | Jan 23, 2026 | 13D/G |
| M28 Capital Management LP | IA, PN | 4.80% | 620,167 | Jan 23, 2026 | 13D/G |
| Kingdon Capital Management, L.L.C. | Investment adviser | 1.50% | 90,000 | Nov 13, 2024 | 13D/G |
| Mark Kingdon | HC, IN | 1.50% | 90,000 | Nov 13, 2024 | 13D/G |
| Kingdon GP, LLC | Other | 1.40% | 81,000 | Nov 13, 2024 | 13D/G |
| M. Kingdon Offshore Master Fund L.P. | Partnership | 1.40% | 81,000 | Nov 13, 2024 | 13D/G |
| Maverick Capital, Ltd. | Investment adviser | 0.40% | 49,554 | Nov 14, 2025 | 13D/G |
| Lee S. Ainslie III | Individual | 0.40% | 49,554 | Nov 14, 2025 | 13D/G |
| Maverick Capital Management, LLC | Holding company | 0.40% | 49,554 | Nov 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,670,930 acquired · 270 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rubin Marc | director | Jul 7, 2026 | AWARD | 6,800 | $5.29 | $36.0K | Form 4 |
| KAITIN KENNETH I | director | Jul 7, 2026 | AWARD | 6,800 | $5.29 | $36.0K | Form 4 |
| Hohneker John | director | Jul 7, 2026 | AWARD | 6,800 | $5.29 | $36.0K | Form 4 |
| GREENACRE MARTYN D | director | Jul 7, 2026 | AWARD | 6,800 | $5.29 | $36.0K | Form 4 |
| Borgman Anne Elizabeth | director | Jul 7, 2026 | AWARD | 6,800 | $5.29 | $36.0K | Form 4 |
| Duvall Diantha | CFO | Jul 7, 2026 | AWARD | 48,285 | $5.29 | $255.4K | Form 4 |
| Zung Jonathan B. | CDO | Jul 7, 2026 | AWARD | 48,285 | $5.29 | $255.4K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jul 7, 2026 | AWARD | 110,090 | $5.29 | $582.4K | Form 4 |
| KAITIN KENNETH I | director | Mar 31, 2026 | BUY | 10,000 | $0.55 | $5.5K | Form 4 |
| Zung Jonathan B. | CDO | Mar 20, 2026 | CONVERSION | 66,667 | — | — | Form 4 |
| Zung Jonathan B. | CDO | Mar 20, 2026 | CONVERSION | 50 | — | — | Form 4 |
| Hamdy Ahmed MD | CMO | Mar 20, 2026 | CONVERSION | 66,667 | — | — | Form 4 |
| Hamdy Ahmed MD | CMO | Mar 20, 2026 | CONVERSION | 50 | — | — | Form 4 |
| Duvall Diantha | CFO | Mar 20, 2026 | CONVERSION | 66,666 | — | — | Form 4 |
| Duvall Diantha | CFO | Mar 20, 2026 | CONVERSION | 50 | — | — | Form 4 |
| Dentzer James E | director, officer: President & CEO | Mar 20, 2026 | CONVERSION | 133,333 | — | — | Form 4 |
| Dentzer James E | director, officer: President & CEO | Mar 20, 2026 | CONVERSION | 100 | — | — | Form 4 |
| Rubin Marc | director | Mar 20, 2026 | CONVERSION | 26,667 | — | — | Form 4 |
| Rubin Marc | director | Mar 20, 2026 | CONVERSION | 20 | — | — | Form 4 |
| Zung Jonathan B. | CDO | Mar 17, 2026 | AWARD | 66,667 | $0.75 | $50.0K | Form 4 |
| Zung Jonathan B. | CDO | Mar 17, 2026 | AWARD | 66,667 | $0.75 | $50.0K | Form 4 |
| Zung Jonathan B. | CDO | Mar 17, 2026 | AWARD | 66,667 | $0.75 | $50.0K | Form 4 |
| Zung Jonathan B. | CDO | Mar 17, 2026 | AWARD | 50 | — | — | Form 4 |
| Hamdy Ahmed MD | CMO | Mar 17, 2026 | AWARD | 66,667 | $0.75 | $50.0K | Form 4 |
| Hamdy Ahmed MD | CMO | Mar 17, 2026 | AWARD | 66,667 | $0.75 | $50.0K | Form 4 |
| Hamdy Ahmed MD | CMO | Mar 17, 2026 | AWARD | 66,667 | $0.75 | $50.0K | Form 4 |
| Hamdy Ahmed MD | CMO | Mar 17, 2026 | AWARD | 50 | — | — | Form 4 |
| Duvall Diantha | CFO | Mar 17, 2026 | AWARD | 66,666 | $0.75 | $50.0K | Form 4 |
| Duvall Diantha | CFO | Mar 17, 2026 | AWARD | 66,666 | $0.75 | $50.0K | Form 4 |
| Duvall Diantha | CFO | Mar 17, 2026 | AWARD | 66,666 | $0.75 | $50.0K | Form 4 |
| Duvall Diantha | CFO | Mar 17, 2026 | AWARD | 50 | — | — | Form 4 |
| Dentzer James E | director, officer: President & CEO | Mar 17, 2026 | AWARD | 133,333 | $0.75 | $100.0K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Mar 17, 2026 | AWARD | 133,333 | $0.75 | $100.0K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Mar 17, 2026 | AWARD | 133,333 | $0.75 | $100.0K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Mar 17, 2026 | AWARD | 100 | — | — | Form 4 |
| Rubin Marc | director | Mar 17, 2026 | AWARD | 26,667 | $0.75 | $20.0K | Form 4 |
| Rubin Marc | director | Mar 17, 2026 | AWARD | 26,667 | $0.75 | $20.0K | Form 4 |
| Rubin Marc | director | Mar 17, 2026 | AWARD | 26,667 | $0.75 | $20.0K | Form 4 |
| Rubin Marc | director | Mar 17, 2026 | AWARD | 20 | — | — | Form 4 |
| Dentzer James E | director, officer: President & CEO | May 20, 2025 | AWARD | 360,000 | $3.13 | $1.1M | Form 4 |
| Hohneker John | director | May 20, 2025 | AWARD | 14,400 | $3.13 | $45.1K | Form 4 |
| GREENACRE MARTYN D | director | May 20, 2025 | AWARD | 14,400 | $3.13 | $45.1K | Form 4 |
| Rubin Marc | director | May 20, 2025 | AWARD | 14,400 | $3.13 | $45.1K | Form 4 |
| Duvall Diantha | CFO | May 20, 2025 | AWARD | 135,000 | $3.13 | $422.6K | Form 4 |
| Borgman Anne Elizabeth | director | May 20, 2025 | AWARD | 14,400 | $3.13 | $45.1K | Form 4 |
| Zung Jonathan B. | CDO | May 20, 2025 | AWARD | 135,000 | $3.13 | $422.6K | Form 4 |
| KAITIN KENNETH I | director | May 20, 2025 | AWARD | 14,400 | $3.13 | $45.1K | Form 4 |
| Hamdy Ahmed MD | CMO | May 1, 2025 | AWARD | 200,000 | $2.48 | $496.0K | Form 4 |
| Hamdy Ahmed MD | officer | May 1, 2025 | OTHER | 0 | — | — | Form 4 |
| Duvall Diantha | CFO | Jan 28, 2025 | AWARD | 15,000 | $3.13 | $47.0K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 28, 2025 | AWARD | 40,000 | $3.13 | $125.2K | Form 4 |
| Zung Jonathan B. | CDO | Jan 28, 2025 | AWARD | 15,000 | $3.13 | $47.0K | Form 4 |
| KAITIN KENNETH I | director | Jan 28, 2025 | AWARD | 1,600 | $3.13 | $5.0K | Form 4 |
| Rubin Marc | director | Jan 28, 2025 | AWARD | 1,600 | $3.13 | $5.0K | Form 4 |
| Borgman Anne Elizabeth | director | Jan 28, 2025 | AWARD | 1,600 | $3.13 | $5.0K | Form 4 |
| Hohneker John | director | Jan 28, 2025 | AWARD | 1,600 | $3.13 | $5.0K | Form 4 |
| GREENACRE MARTYN D | director | Jan 28, 2025 | AWARD | 1,600 | $3.13 | $5.0K | Form 4 |
| Duvall Diantha | CFO | May 21, 2024 | AWARD | 39,000 | $11.62 | $453.2K | Form 4 |
| Dentzer James E | director, officer: President & CEO | May 21, 2024 | AWARD | 100,000 | $11.62 | $1.2M | Form 4 |
| Zung Jonathan B. | CDO | May 21, 2024 | AWARD | 40,700 | $11.62 | $472.9K | Form 4 |
| KAITIN KENNETH I | director | May 21, 2024 | AWARD | 4,250 | $11.62 | $49.4K | Form 4 |
| Rubin Marc | director | May 21, 2024 | AWARD | 4,250 | $11.62 | $49.4K | Form 4 |
| Borgman Anne Elizabeth | director | May 21, 2024 | AWARD | 4,250 | $11.62 | $49.4K | Form 4 |
| Hohneker John | director | May 21, 2024 | AWARD | 4,250 | $11.62 | $49.4K | Form 4 |
| GREENACRE MARTYN D | director | May 21, 2024 | AWARD | 4,250 | $11.62 | $49.4K | Form 4 |
| Zung Jonathan B. | CDO | May 1, 2023 | AWARD | 500,000 | $0.83 | $415.0K | Form 4 |
| Zung Jonathan B. | officer | May 1, 2023 | OTHER | 0 | — | — | Form 4 |
| KAITIN KENNETH I | director | Jan 23, 2023 | AWARD | 85,000 | — | — | Form 4 |
| Hohneker John | director | Jan 23, 2023 | AWARD | 85,000 | — | — | Form 4 |
| Rubin Marc | director | Jan 23, 2023 | AWARD | 85,000 | — | — | Form 4 |
| GREENACRE MARTYN D | director | Jan 23, 2023 | AWARD | 85,000 | — | — | Form 4 |
| Borgman Anne Elizabeth | director | Jan 23, 2023 | AWARD | 85,000 | — | — | Form 4 |
| Duvall Diantha | CFO | Jan 20, 2023 | AWARD | 500,000 | — | — | Form 4 |
| Martell Robert | Head of Research & Development | Jan 20, 2023 | AWARD | 350,000 | — | — | Form 4 |
| Dentzer James E | President & CEO | Jan 20, 2023 | AWARD | 1,000,000 | — | — | Form 4 |
| Borgman Anne Elizabeth | director | Oct 12, 2022 | AWARD | 25,000 | — | — | Form 4 |
| Borgman Anne Elizabeth | director: | Oct 12, 2022 | OTHER | 0 | — | — | Form 4 |
| Duvall Diantha | CFO | Aug 5, 2022 | DISPOSED | 540,000 | $1.12 | $604.8K | Form 4 |
| Rubin Marc | director | Jan 31, 2022 | AWARD | 85,000 | $3.19 | $271.1K | Form 4 |
| Kunkel Lori Anne | director | Jan 31, 2022 | AWARD | 85,000 | $3.19 | $271.1K | Form 4 |
| KAITIN KENNETH I | director | Jan 31, 2022 | AWARD | 85,000 | $3.19 | $271.1K | Form 4 |
| Hohneker John | director | Jan 31, 2022 | AWARD | 85,000 | $3.19 | $271.1K | Form 4 |
| GREENACRE MARTYN D | director | Jan 31, 2022 | AWARD | 85,000 | $3.19 | $271.1K | Form 4 |
| Steinkrauss William | Chief Financial Officer | Jan 29, 2022 | AWARD | 360,000 | $3.09 | $1.1M | Form 4 |
| Martell Robert | Head of Research & Development | Jan 29, 2022 | AWARD | 252,000 | $3.09 | $778.7K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 29, 2022 | AWARD | 825,000 | $3.09 | $2.5M | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 27, 2022 | SELL | 2,406 | $3.18 | $7.7K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 31, 2022 | SELL | 3,094 | $3.07 | $9.5K | Form 4 |
| Hohneker John | director | Dec 2, 2021 | AWARD | 25,000 | $4.77 | $119.2K | Form 4 |
| Hohneker John | director: | Dec 2, 2021 | OTHER | 0 | — | — | Form 4 |
| GREENACRE MARTYN D | director | Jan 28, 2021 | AWARD | 33,000 | $9.14 | $301.6K | Form 4 |
| Martell Robert | Head of Research & Development | Jan 28, 2021 | AWARD | 126,000 | $9.14 | $1.2M | Form 4 |
| Rubin Marc | director | Jan 28, 2021 | AWARD | 33,000 | $9.14 | $301.6K | Form 4 |
| Steinkrauss William | Chief Financial Officer | Jan 28, 2021 | AWARD | 180,000 | $9.14 | $1.6M | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 28, 2021 | AWARD | 330,000 | $9.14 | $3.0M | Form 4 |
| KAITIN KENNETH I | director | Jan 28, 2021 | AWARD | 33,000 | $9.14 | $301.6K | Form 4 |
| Kunkel Lori Anne | director | Jan 28, 2021 | AWARD | 33,000 | $9.14 | $301.6K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 25, 2021 | SELL | 2,283 | $10.96 | $25.0K | Form 4 |
| Dentzer James E | director, officer: President & CEO | Jan 26, 2021 | SELL | 3,094 | $10.59 | $32.8K | Form 4 |
| KAITIN KENNETH I | director | Mar 2, 2020 | AWARD | 180,000 | $1.26 | $226.8K | Form 4 |